Inventor · disambiguated record
Jean Haensler
Also filed as: HAENSLER JEAN
19 granted patents·18 pending applications·673 citations·filing 1995–2025
95Inventor score
Top patents by PatentIndex Score
37 records- 0197US5661025ASelf-assembling polynucleotide delivery system comprising dendrimer polycationsUNIV CALIFORNIA·Filed 1995·Granted Aug 26, 1997·192 cites·6 claims
- 0291US6113946ASelf-assembling polynucleotide delivery system comprising dendrimer polycationsUNIV CALIFORNIA·Filed 1995·Granted Sep 5, 2000·90 cites·64 claims
- 0388US6300317B1Self-assembling polynucleotide delivery systemUNIV CALIFORNIA·Filed 1995·Granted Oct 9, 2001·68 cites·67 claims
- 0485US5977084ASelf-assembling polynucleotide delivery methodUNIV CALIFORNIA·Filed 1995·Granted Nov 2, 1999·53 cites·49 claims
- 0582US6126938AMethods for inducing a mucosal immune responsePASTEUR MERIEUX SERUMS VACC·Filed 1998·Granted Oct 3, 2000·56 cites·28 claims
- 0681US7344720B2Vaccine compositionSANOFI PASTEUR SA·Filed 2004·Granted Mar 18, 2008·12 cites·7 claims
- 0780US6610308B1Immunostimulant emulsionAVENTIS PASTEUR S A·Filed 1999·Granted Aug 26, 2003·44 cites·14 claims
- 0880US5955365ASelf-assembling polynucleotide delivery systemUNIV CALIFORNIA·Filed 1995·Granted Sep 21, 1999·38 cites·33 claims
- 0978US6780421B1Adjuvant for a vaccine compositionAVENTIS PASTEUR SA·Filed 1995·Granted Aug 24, 2004·50 cites·25 claims
- 1077US9504659B2Thermoreversible oil-in-water emulsionKLUCKER MARIE-FRANÇOISE·Filed 2007·Granted Nov 29, 2016·5 cites·3 claims
- 1174US9327021B2Immunogenic compositionsGALLICHAN SCOTT·Filed 2011·Granted May 3, 2016·4 cites·17 claims
- 1272US6124270AUse of a cationic amphipathic compound as a transfection agent, vaccine additive or drugPASTEUR MERIEUX SERUMS VACC·Filed 1996·Granted Sep 26, 2000·39 cites·17 claims
- 1372US2023277655A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2022·Application pending·0 cites
- 1471US5990089ASelf-assembling polynucleotide delivery system comprising dendrimer polycationsUNIV CALIFORNIA·Filed 1995·Granted Nov 23, 1999·20 cites·5 claims
- 1568US9770505B2Vaccine composition with aluminium hydroxide nanoparticlesMATHIEU YANNICK·Filed 2012·Granted Sep 26, 2017·2 cites·18 claims
- 1665US11207403B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2020·Granted Dec 28, 2021·0 cites·13 claims
- 1765US2005118188A1Pharmaceutical composition for immunization against AIDSAVENTIS PASTEUR S A·Filed 2004·Application pending·0 cites
- 1864US11524069B2Human cytomegalovirus immunogenic compositionSANOFI PASTEUR·Filed 2018·Granted Dec 13, 2022·0 cites·20 claims
- 1964US2025228933A1Human Cytomegalovirus Immunogenic CompositionSANOFI PASTEUR·Filed 2025·Application pending·0 cites
- 2060US7767658B2Vaccine compositionAVENTIS PASTEUR SA·Filed 2008·Granted Aug 3, 2010·0 cites·6 claims
- 2160US2007087009A1Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonistSANOFI PASTEUR·Filed 2004·Application pending·0 cites
- 2258US2023293447A1Cleavable lipidic compounds, compositions containing thereof, and uses thereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 2357US2003190326A1Pharmaceutical composition for immunisation against aidsFiled 2001·Application pending·0 cites
- 2457US2004038922A1Vaccine compositionFiled 2001·Application pending·0 cites
- 2556US2005002952A1Adjuvant for vaccine compositionAVENTIS PASTEUR SA·Filed 2004·Application pending·0 cites
- 2651US8506971B2Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteriaHAENSLER JEAN·Filed 2010·Granted Aug 13, 2013·0 cites·8 claims
- 2751US2003120060A1Human cytomegalovirus DNA constructs and uses thereforFiled 2002·Application pending·0 cites
- 2850US2013295164A1Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteriaSANOFI PASTEUR S A·Filed 2013·Application pending·0 cites
- 2950US2023295097A1Lipidic compounds comprising at least one terminal radical of formula -nh-cx-a or -nh-cx-nh-a, compositions containing them and uses thereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 3049US2010291192A1Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteriaSANOFI PASTEUR·Filed 2010·Application pending·0 cites
- 3149US2023398211A1Liposomes Containing TLR4 Agonist, Preparation and Uses ThereofSANOFI PASTEUR·Filed 2021·Application pending·0 cites
- 3247US2017326221A1Detoxification method for lipopolysaccharide (LPS) or lipid A of Gram-negative bacteriaHAENSLER JEAN·Filed 2017·Application pending·0 cites
- 3345US2016367655A1Immunogenic CompositionsSANOFI PASTEUR LTD·Filed 2016·Application pending·0 cites
- 3441US2010247557A1Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 AgonistSANOFI PASTEUR·Filed 2010·Application pending·0 cites
- 3540US11554170B2Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvantsBOEHRINGER INGELHEIM ANIMAL HEALTH USA INC·Filed 2017·Granted Jan 17, 2023·0 cites·16 claims
- 3640US2004033240A1Immunological combinations for prophylaxis and therapy of helicobacter pylori infectionFiled 2001·Application pending·0 cites
- 3728US2012156281A1Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis ProteinHAENSLER JEAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean Haensler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →